NextPlat subsidiary awarded services contract from DevotedDOc

NextPlat (NXPL) announced that its PharmcoRx subsidiary has been awarded a new multi-state prescription fulfillment services contract from DevotedDOc. DevotedDOc is a virtual medical group offering an array of services including urgent care and Medication-Assisted Treatment, or MAT, for opioid use disorder, as well as compounded alternatives to GLP-1s including semaglutide, or Wegovy and Ozempic, and tirzepatide, or Zepbound and Mounjaro, for weight loss and Hormone Replacement therapy, or HRT. It currently services patients virtually nationwide and provides in-person care at clinic locations in Florida, Oklahoma, New Mexico and Georgia. Under terms of the exclusive new agreement, PharmcoRX will commence prescription fulfillment services for patients in Florida and Georgia in November. The Company is working to further expand its fulfillment services beyond Florida and Georgia with DevotedDOc nationally as PharmcoRx is also a licensed non-resident pharmacy in Arizona, Colorado, Connecticut, Illinois, Minnesota, Nevada, New Jersey, New York, Pennsylvania, Texas, and Utah.